Founders Fund is a San Francisco-based multi-stage venture capital firm founded in 2005. It invests from seed through growth in frontier technology categories and is known for its founder-driven, highly contrarian approach. The firm backs companies pursuing large, difficult markets and has the scale to invest from early rounds through very large late-stage financings.

The firm has a strong track record in breakthrough technology and has invested in major neurotech and frontier science companies including Neuralink. More broadly, its portfolio reflects deep conviction in sectors such as aerospace, defense, AI, biotech, and advanced manufacturing. Founders Fund is particularly known for supporting technically ambitious companies that require long development timelines and substantial capital.

Founders Fund invests globally, with its strongest presence in North America and meaningful reach into Europe and other major innovation hubs. For neurotech, it is best understood as a high-conviction investor for category-defining platforms rather than a broad healthcare generalist. Its relevance is greatest for companies building highly ambitious neural interface, neuroengineering, or frontier bio platforms at significant scale.